Literature DB >> 18307664

Living donor liver transplantation for acute liver failure in infants: the impact of unknown etiology.

Seisuke Sakamoto1, Hironori Haga, Hiroto Egawa, Mureo Kasahara, Kohei Ogawa, Yasutsugu Takada, Shinji Uemoto.   

Abstract

Infants with ALF occasionally have the most urgent need for a liver transplant. In urgent situations for liver transplantation, LDLT has been advocated. Between July 1995 and April 2004, medical records of 15 infants undergoing LDLT for ALF of unknown etiology were reviewed and their outcomes were compared with infants undergoing LDLT for other liver diseases. They received LLS (n = 9), MS (n = 3), and RMS (n = 3) grafts. Eight technical complications occurred, with a similar incidence for LDLT and the other liver diseases. On the other hand, the liver biopsies after LDLT showed a significantly higher incidence of ACR with centrilobular injuries. Ten patients died after primary LDLT because of refractory rejection (n = 6), rotavirus infection (n = 2), chronic rejection (n = 1), and surgical complications (n = 1). With a median follow-up of 7.0 months, five-yr graft and patient survival rates were 17.8% and 26.7%, respectively. In conclusion, the outcome of LDLT for ALF in infants, especially cases with unknown etiology, was unsatisfactory and refractory rejection often led to liver failure. From our observation the centrilobular changes were characteristics of ACR in infantile LDLT for cryptogenic ALF.

Entities:  

Mesh:

Year:  2008        PMID: 18307664     DOI: 10.1111/j.1399-3046.2007.00718.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  6 in total

1.  Left-sided grafts for living-donor liver transplantation and split grafts for deceased-donor liver transplantation: their impact on long-term survival.

Authors:  Tomohide Hori; Shinji Uemoto; Lindsay B Gardner; Lena Sibulesky; Yasuhiro Ogura; Justin H Nguyen
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-09-28       Impact factor: 2.947

2.  Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure.

Authors:  Pradip Kamat; Sachin Kunde; Miriam Vos; Atul Vats; Nitika Gupta; Thomas Heffron; Rene Romero; James D Fortenberry
Journal:  Pediatr Crit Care Med       Date:  2012-01       Impact factor: 3.624

3.  Muromonab-CD3 for the successful treatment of early chronic rejection after pediatric liver transplantation: report of a case.

Authors:  Tomohide Hori; Justin H Nguyen; Shinji Uemoto
Journal:  Surg Today       Date:  2011-03-23       Impact factor: 2.549

4.  Impact of the current organ allocation system for deceased donor liver transplantation on the outcomes of pediatric recipients: a single center experience in Japan.

Authors:  Seisuke Sakamoto; Hajime Uchida; Ikumi Hamano; Takanobu Shigeta; Kengo Sasaki; Hiroyuki Kanazawa; Akinari Fukuda; Mureo Kasahara
Journal:  Pediatr Surg Int       Date:  2013-11       Impact factor: 1.827

Review 5.  Current status of pediatric transplantation in Japan.

Authors:  Nao Nishimura; Mureo Kasahara; Kenji Ishikura; Satoshi Nakagawa
Journal:  J Intensive Care       Date:  2017-07-20

6.  Acute liver failure in children-Is living donor liver transplantation justified?

Authors:  Marek Szymczak; Piotr Kaliciński; Grzegorz Kowalewski; Dorota Broniszczak; Małgorzata Markiewicz-Kijewska; Hor Ismail; Marek Stefanowicz; Adam Kowalski; Joanna Teisseyre; Irena Jankowska; Waldemar Patkowski
Journal:  PLoS One       Date:  2018-02-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.